Dermatology & Immunodermatology Solutions
Translational models and assays to advance your pipeline from Discovery to Clinical Testing
Are you seeking validated or innovative assays to demonstrate the efficacy of your dermatological formulations? Need to characterize active ingredients, confirm mechanism of action, or screen for target engagement early in development?
At QIMA Life Sciences, we provide scientifically grounded, clinically relevant solutions to support the development of treatments for skin disorders, including psoriasis, atopic dermatitis, hidradenitis suppurativa, and chronic urticaria, phemphigoid diseases, etc.
From Biomarkers to Mechanism of Action
Our platforms are designed to assess many biomarkers such as:
- Cytokine inhibition (e.g. IL-4, IL-13, IL-17, IL-23, TSLP)
- JAK/STAT pathway modulation
- Type I interferon signaling
- Barrier restoration and immune cell activation
We help characterize your compounds using quantitative biomarkers, phospho-protein readouts, cellular responses, and gene expression profiling — ensuring mechanistic insight and translational value.
Whether you’re developing small molecules, biologics, biosimilars, peptides, monoclonal or bispecific antibodies, etc, our in vitro, ex vivo, and functional assays support rapid and reproducible evaluation of immunomodulatory activity and therapeutic potential.
Integrated Preclinical and Clinical Research Capabilities
QIMA Life Sciences offers a seamless continuum of research services, from early-stage discovery to clinical evaluation:
Preclinical Services:
-
In vitro & ex vivo screening of active compounds
-
In vivo efficacy models
-
Mechanism of action studies
-
Safety testing and regulatory-oriented protocols
-
Advanced co-culture systems for complex disease modeling
Clinical Services:
Our dedicated clinical unit sites enable early-phase studies, includingPhase I and Phase IIa clinical trials.
We also offer advanced clinical skin imaging analysis, powered by proprietary AI-based algorithms for automated and quantitative analysis of dermatological parameters. Our solutions also include standardized image capture systems, enabling consistent and objective data collection across study sites.
Tailored Study Design & Scientific Guidance
Our expert team works with you to:
-
Select the most relevant models based on disease context and target biology
-
Customize study design to match your regulatory and scientific goals
-
Provide regular updates, transparent reporting, and expert interpretation
A Trusted Partner in Immunodermatology Innovation
With over 20 years of experience in skin biology, immunopharmacology, and biomarker-based development, QIMA Life Sciences is your partner to de-risk and accelerate the journey from early discovery to clinical translation.
Let us help you bring your next dermatology breakthrough to life — with science at the core.
Unique Access to Human Skin & Hair Samples
We provide access to a diverse biobank of healthy and pathological skin and hair samples, collected through our network of dermatologists and surgeons. These samples are used to:
- Isolate primary cells from diseased tissue
- Identify targets
- Identify and validate disease-specific biomarkers
- Maintain functional ex vivo organ cultures for compound testing
This ensures high physiological relevance for early efficacy and safety evaluation.